Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04452682
Recruitment Status : Completed
First Posted : June 30, 2020
Last Update Posted : June 30, 2020
Sponsor:
Information provided by (Responsible Party):
Mansoura University

Brief Summary:
This is a retrospective analytical study conducted at Vascular and Endovascular surgery Department, Mansoura University Hospital, including all patients admitted at the two periods first six months of 2019 and 2020.To demonstrate the effect of COVID-19 pandemic on the practice of emergency vascular surgery and critical limb threatening ischemia interventions by comparison two periods first six months of 2019 and 2020.

Condition or disease Intervention/treatment
COVID Critical Limb Ischemia Other: COVID 19 impact

Show Show detailed description

Layout table for study information
Study Type : Observational
Actual Enrollment : 998 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice
Actual Study Start Date : May 25, 2020
Actual Primary Completion Date : June 21, 2020
Actual Study Completion Date : June 21, 2020

Group/Cohort Intervention/treatment
Era of COVID 19
Total number of cases admitted during first six months of 2020
Other: COVID 19 impact
The impact of COVID-19 pandemic on Critical limb threatening ischemia and emergency vascular practice

Era of Non COVID 19
Total number of cases admitted the first six months of 2019



Primary Outcome Measures :
  1. The ICU admission with associated Pneumonia [ Time Frame: 6 months ]
    The ICU admission caused by Pneumonia proved radio-logically at both periods

  2. Impact of COVID-19 on the different presentation of vascular surgery at the emergency [ Time Frame: 6 months ]
    percentage of different diagnoses at both periods


Secondary Outcome Measures :
  1. Mortality rates [ Time Frame: 6 months ]
    Mortality percentages at both periods



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sampling Method:   Non-Probability Sample
Study Population
It will include all patients presented to our department at the first 6 months of 2019 and first 6 months of 2020.
Criteria

Inclusion Criteria:

  • All patients admitted to our department at that periods.

Exclusion Criteria:

  • Patients can't give consent (unconscious).
  • Those with mental or behavioral disorders will be excluded.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04452682


Locations
Layout table for location information
Egypt
Mansoura university
Mansoura, Egypt, 35511
Sponsors and Collaborators
Mansoura University
Layout table for additonal information
Responsible Party: Mansoura University
ClinicalTrials.gov Identifier: NCT04452682    
Other Study ID Numbers: R.20.06.898 - 2020/06/16
First Posted: June 30, 2020    Key Record Dates
Last Update Posted: June 30, 2020
Last Verified: June 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Emergencies
Ischemia
Disease Attributes
Pathologic Processes